Home > PE Ratio > MERCURY LABORATORIES

MERCURY LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of MERCURY LABORATORIES is 23.51.

Share Price ₹979.0Nov 08,2024
Market Cap ₹117.5 Cr
Earnings-TTM₹5.0 CrTTM-Standalone Results
Price/Earnings23.51xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for MERCURY LABORATORIES
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of MERCURY LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of MERCURY LABORATORIES is calculated as :

Current Market Cap [ ₹117.5 Cr] as on Nov 08,2024

(/) Earnings [ ₹5.0 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 23.51x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for MERCURY LABORATORIES , the investors are currently willing to pay 23.51 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MERCURY LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of MERCURY LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of MERCURY LABORATORIES


PE Ratio Performance Analysis for MERCURY LABORATORIES

- MERCURY LABORATORIES 's latest p/e ratio is 23.51x.

- MERCURY LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 14.30x.

- MERCURY LABORATORIES 's operated at median p/e ratio of 14.45x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MERCURY LABORATORIES 's p/e ratio peaked in Mar2024 at 17.66x.

- MERCURY LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 10.45x.


How does MERCURY LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
MERCURY LABORATORIES 5.0023.51117.5
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5039.03434,604.0
CIPLA LTD4,485.2228.66128,549.0
DR REDDYS LABORATORIES LTD5,406.8019.78106,956.0
ZYDUS LIFESCIENCES LTD4,181.9023.3197,468.9
DIVIS LABORATORIES LTD1,836.0085.86157,639.0
MANKIND PHARMA LTD2,124.8650.13106,527.0
TORRENT PHARMACEUTICALS LTD1,802.0060.01108,130.0
LUPIN LTD2,651.9436.2095,997.1
AUROBINDO PHARMA LTD3,533.2221.8277,104.3
ABBOTT INDIA LTD1,284.6647.2660,713.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MERCURY LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.78x
Max industry PE 85.86x
Median industry PE 36.20x
Average industry PE 39.60x



You may also like the below Video Courses